Tomi Environmental Solutions I Stock Price, News & Analysis

TOMI Environmental Solutions (NASDAQ: TOMZ) secured a signed purchase order valued at approximately $500,000 from a global biopharmaceutical leader to integrate the SteraMist iHP technology into passthrough fill boxes used in sterile manufacturing.

The contract covers full integration of the SteraMist Integrated Systems (SIS) platform across two manufacturing areas and includes comprehensive installation and performance qualification (PQ) services to meet regulatory validation requirements. The projects were previously included in a stated $13 million automated-installation pipeline, and TOMI expects further orders through 2026 and beyond.

TOMI Environmental Solutions (NASDAQ:TOMZ) on Dec. 15, 2025 urged cruise lines to adopt hospital-grade decontamination technology such as SteraMist to improve passenger and crew safety. TOMI highlighted cruise ships as concentrated, high‑risk environments for pathogens like Norovirus and Legionella and referenced recent outbreaks to argue for proactive, comprehensive disinfection beyond traditional cleaning.

The release says SteraMist can treat high‑risk areas (dining, crew quarters, clinics, children’s play areas, outdoor furniture), enable faster outbreak containment, reduce downtime, and increase passenger confidence. TOMI invites cruise operators and the public to partner with the company and provides contact info for assistance.

TOMI Environmental Solutions (NASDAQ:TOMZ) will present at the Sidoti Year End Investor Conference on December 11, 2025 at 2:30 PM ET. CEO Dr. Halden Shane and CFO David Vanston will be available for one-on-one meetings during the virtual conference on December 10-11, 2025. The presentation will cover TOMI's Binary Ionization Technology (BIT) platform and SteraMist product line for disinfection and decontamination.

Investors can register to watch the virtual presentation and contact investor relations at tomi@imsinvestorrelations.com for meeting requests.

TOMI Environmental Solutions (NASDAQ: TOMZ) announced a custom integration pipeline valued at approximately $3 million focused on life sciences and medical device customers. The company reports ten active projects across its SteraMist Integrated System (SIS) and Custom Engineered System (CES) platforms and multiple projects scheduled for completion before year-end.

Strategic partnerships with enclosure manufacturers including ESCO, Steelco, PBSC, Nuaire, and Getinge are cited as drivers of platform growth and broader distribution for integrated iHP decontamination solutions.

TOMI Environmental Solutions (NASDAQ: TOMZ) filed a $50 million universal shelf registration statement on Form S-3 with the SEC on November 17, 2025, enabling the company to offer and sell securities from time to time up to the aggregate amount once the shelf is declared effective.

Concurrent with the filing, TOMI entered a strategic advisory and placement arrangement with Bancroft Capital and established an equity line of credit (ELOC) with Hudson Global Ventures, LLC that allows TOMI to sell up to $20,000,000 of common stock over a 24-month period. Management cited Q3 sequential revenue growth, improved gross margins, and expanding adoption of SteraMist technology as drivers for pursuing added financing flexibility to support growth, manufacturing, product development, and global distribution.

TOMI Environmental Solutions (NASDAQ:TOMZ) reported Q3 2025 results on Nov 14, 2025, highlighting a 95% sequential revenue increase to $2.01M and maintained 61% gross margin. Quarterly net loss was $(450,000) or $(0.02) per share versus net income a year earlier. Nine‑month sales fell to $4.62M from $6.67M and operating loss widened to $(2.21M) year‑to‑date.

Commercially, backlog rose from $0.9M at quarter‑end to $1.3M on Oct 31, with ~$3M in pending contracts; SteraMist solution sales were up 21% YTD. Liquidity actions include a $535k convertible note, a $20M equity line (24 months) and intent to file a Form S‑3 shelf up to $50M.

TOMI Environmental Solutions (NASDAQ: TOMZ) will report third quarter results for the period ended September 30, 2025 after market close on Friday, November 14, 2025. The company will host a conference call the same day at 4:30 p.m. ET with phone participation instructions and participant code 690402. International dial-in and a live webcast are available, and the press release and webcast will be accessible from the Investor Relations section or via the provided registration link.

A teleconference replay will be available through November 28, 2025 (replay code 53230), and a webcast replay will remain on the company website for at least 90 days. For investor inquiries, contact IMS Investor Relations at tomi@imsinvestorrelations.com.

TOMI Environmental Solutions (NASDAQ: TOMZ) will participate and speak at the American Association for Laboratory Animal Science (AALAS) 76th National Meeting in Long Beach, CA, Nov 9-13, 2025. TOMI plans to showcase its SteraMist Integrated System (SIS) and ionized Hydrogen Peroxide (iHP) technology to animal research professionals, pursue distributor meetings including ARES Scientific, and highlight product integration and adoption opportunities.

The company said its executive team, led by COO Elissa J. Shane, will present to support lead generation, strategic partnerships, and expanded distribution in the animal research sector.

TOMI Environmental Solutions (NASDAQ: TOMZ) will present at the LD Micro Main Event XIX on Tuesday, October 21, 2025 at 10:00 AM PT at the Hotel del Coronado. Dr. Halden Shane, CEO and chairman, will deliver the presentation. The three-day conference runs October 19–21, 2025, features about 120 companies, half-hour company presentations, and one-on-one investor meetings. A virtual registration link is available for investors to watch the presentation.